Gallamine triethiodide
Systematic (IUPAC) name | |
---|---|
2,2’,2’’-[benzene-1,2,3-triyltris(oxy)]tris(N,N,N-triethylethanaminium) triiodide | |
Clinical data | |
Trade names | Flaxedil |
AHFS/Drugs.com | International Drug Names |
Identifiers | |
65-29-2 | |
M03AC02 | |
PubChem | CID 6172 |
IUPHAR ligand | 356 |
DrugBank | DB00483 |
ChemSpider | 5937 |
UNII | Q3254X40X2 |
KEGG | D02292 |
ChEBI | CHEBI:503442 |
ChEMBL | CHEMBL1200993 |
Chemical data | |
Formula |
C30H60N3O3+3 · 3 I− (gallamine triethiodide) C24H45N3O3 (gallamine) |
891.529 g/mol (gallamine triethiodide) 423.633 g/mol (gallamine) | |
SMILES
| |
| |
(what is this?) (verify) |
Gallamine triethiodide (Flaxedil) is a non-depolarising muscle relaxant.[1] It acts by combining with the cholinergic receptor sites in muscle and competitively blocking the transmitter action of acetylcholine.[2] Gallamine triethiodide has a parasympatholytic effect on the cardiac vagus nerve which causes tachycardia[3][4] and occasionally hypertension. Very high doses cause histamine release.
Gallamine triethiodide is commonly used to stabilize muscle contractions during surgical procedures.
It was developed by Daniel Bovet in 1947.[5]
The pharmaceutical is no longer marketed in the United States, according to the FDA Orange Book.
References
- ↑ "Webster's Online Dictionary - Flaxedil". Retrieved 2008-12-15.
- ↑ "RxMed: Pharmaceutical Information - FLAXEDIL". Retrieved 2008-12-15.
- ↑ Morgenstern C, Splith G (October 1965). "[Studies on the causes of gallamine tachycardia and its antagonistic modification by beta adrenolytics]". Der Anaesthesist (in German) 14 (10): 298–301. PMID 4380161.
- ↑ WALTS LF (1963). "Ventricular tachycardia with gallamine and cyclopropane anesthesia". Anesthesiology 24: 119. doi:10.1097/00000542-196301000-00024. PMID 13998750. Retrieved 2014-09-20.
- ↑ Raghavendra T (July 2002). "Neuromuscular blocking drugs: discovery and development". J R Soc Med 95 (7): 363–7. doi:10.1258/jrsm.95.7.363. PMC 1279945. PMID 12091515.
|